Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Tateishi

Showing results (11-20 of 273) with videos related to

Pageof 28
Sort By:
Clinical Journal of Gastroenterology|May 29, 2019
Successful treatment of chronic hepatitis C virus infection with crushed glecaprevir/pibrentasvir administered via a percutaneous endoscopic gastrostomy tube: case report and review of the literatureYasuo Tanaka, Ryosuke Tateishi, Kazuhiko Koike
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2021
Changing clinical management of NAFLD in AsiaTakuma Nakatsuka, Ryosuke Tateishi, Kazuhiko Koike
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Fibrosis progression in hepatitis C]Ryosuke Tateishi, Haruhiko Yoshida, Masao Omata
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ]Haruhiko Yoshida, Ryosuke Tateishi, Masao Omata
International Journal of Molecular Sciences|October 10, 2018
Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular CarcinomaYasuo Tanaka, Ryosuke Tateishi, Kazuhiko Koike
Journal of Hepatology|July 11, 2024
Reply to: "Validation of SMART model for HCC risk stratification in genotype-4 HCV patients following SVR and its comparison with GES score"Tatsuya Minami, Mitsuhiro Fujishiro, Ryosuke Tateishi
Clinical and Molecular Hepatology|February 2, 2026
Post-Transplant Hepatocellular Carcinoma: Balancing Immunosuppression and Immune Checkpoint InhibitorsTomoharu Yamada, Ryosuke Tateishi, Mitsuhiro Fujishiro
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 11, 2024
[Treatment of hepatocellular carcinoma and risk of decompensation and liver failure]Tatsuya Minami, Ryosuke Tateishi, Mitsuhiro Fujishiro
Journal of Hepato-Biliary-Pancreatic Sciences|November 11, 2009
Staging systems: is there a surgical staging and a medical one?: hepatologist's perspectiveRyota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 23, 2025
Biopsy After Ablation: Expanding the Frontier of Genomic InsightTakuma Nakatsuka, Hayato Nakagawa, Mitsuhiro Fujishiro, et al.
Pageof 28

Showing results (11-20 of 273) with videos related to

Sort By:
Pageof 28
Clinical Journal of Gastroenterology|May 29, 2019
Successful treatment of chronic hepatitis C virus infection with crushed glecaprevir/pibrentasvir administered via a percutaneous endoscopic gastrostomy tube: case report and review of the literatureYasuo Tanaka, Ryosuke Tateishi, Kazuhiko Koike
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2021
Changing clinical management of NAFLD in AsiaTakuma Nakatsuka, Ryosuke Tateishi, Kazuhiko Koike
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Fibrosis progression in hepatitis C]Ryosuke Tateishi, Haruhiko Yoshida, Masao Omata
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ]Haruhiko Yoshida, Ryosuke Tateishi, Masao Omata
International Journal of Molecular Sciences|October 10, 2018
Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular CarcinomaYasuo Tanaka, Ryosuke Tateishi, Kazuhiko Koike
Journal of Hepatology|July 11, 2024
Reply to: "Validation of SMART model for HCC risk stratification in genotype-4 HCV patients following SVR and its comparison with GES score"Tatsuya Minami, Mitsuhiro Fujishiro, Ryosuke Tateishi
Clinical and Molecular Hepatology|February 2, 2026
Post-Transplant Hepatocellular Carcinoma: Balancing Immunosuppression and Immune Checkpoint InhibitorsTomoharu Yamada, Ryosuke Tateishi, Mitsuhiro Fujishiro
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 11, 2024
[Treatment of hepatocellular carcinoma and risk of decompensation and liver failure]Tatsuya Minami, Ryosuke Tateishi, Mitsuhiro Fujishiro
Journal of Hepato-Biliary-Pancreatic Sciences|November 11, 2009
Staging systems: is there a surgical staging and a medical one?: hepatologist's perspectiveRyota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 23, 2025
Biopsy After Ablation: Expanding the Frontier of Genomic InsightTakuma Nakatsuka, Hayato Nakagawa, Mitsuhiro Fujishiro, et al.
Pageof 28